Ananta Medicare Ltd. specializes in manufacturing  of medicines (Cephalosporins),  herbal medicines and  food supplements.  Manufacturing facilities are GMP, ISO 9001, ISO 22000, HACCP certified and situated in Italy, Japan, India. Products are manufactured in the form of parenterals, tablets, capsules, syrups, lozenges, creams, ointments and others. Company’s main fields are gynecology, therapeutics, pediatrics, cardiology, urology, neurology, endocrinology, gastroenterology,  cosmetology, OTC.   Ananta Medicare Ltd has occupied exceptionally firm positions in the CIS countries since 1999. We are looking for a distributors/partners for our products worldwide.
Ananta Medicare’s first plant, which specializes in herbal medicines & food supplements, was launched in 2015.
The products are manufactured in the forms of tablets, capsules, syrups, lozenges, powders, creams/gels, ointments, and others.
The second plant of Ananta Medicare is to be launched in 2020. It will manufacture cephalosporin antibiotics in oral and parenteral forms.
The third plant will have been launched by 2021. Its specialization will be lyophilized and liquid injections.
The total area of the medicine manufacturing plants is about 30,000 sq. m.Manufacturing and quality control systems of these plants have been designed in compliance
with the PIC/S GMP requirements such as MHRA , FDA, etc.

Related Categories

Sales Markets

Middle East Region (e.g. UAE); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)